Companies/Cipher Pharmaceuticals Inc.

Company profile

Cipher Pharmaceuticals Inc.

OTC: CPHRF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Mississauga, ONReports USD

#432 of 1,402 Healthcare companies by revenuetop-quartile growth

EA Score

84B+

FH 92DQ —GM 74SS 57

v0.1 · 45/100 weight · provisional

↑ net margin, operating margin · ↓ workforce scale, disclosure history

Methodology →

Revenue TTM

$51.0M

Rev growth YoY (TTM)

+28.9%

Net income (FY)

$27.8M

Employees

Market cap

$298.9M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$51.3M$51.3M2025

Net income$27.8M$27.8M2025

Operating income$16.8M$16.8M2025

Total assets$156.2M$156.2M2025

Liabilities$30.2M$30.2M2025

Equity$126.0M$126.0M2025

Revenue trend

FY2018 – FY2025 · USD

$22.7M

FY18

$22.5M

FY19

$21.6M

FY20

$21.9M

FY21

$20.7M

FY22

$21.2M

FY23

$33.4M

FY24

$51.3M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Cipher Pharmaceuticals Inc. booked $51.3M in FY2025 revenue, growing 54% year over year — faster than most Healthcare companies we track, at a 54.2% net margin.

Peers · Healthcare

MacroGenics, Inc.54D OraSure Technologies, Inc.67B Entrada Therapeutics, Inc.46D Galectin Therapeutics Inc.——

Key facts

CEOCraig J. Mull

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersMississauga, ON

ExchangeOTC: CPHRF

Employees6

IPO date2006-02-02

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.